Infection with SARS-CoV-2, the causative agent of COVID-19, causes numerous cellular dysfunctions. The virus enters the host cells and hijacks the cell machinery for its replication, resulting in disturbances of the oxidative, reductive balance, increased production of damaging reactive oxygen species (ROS), and mitochondrial dysfunction. This damaging cycle can make cells less resistant to infection and make the host more likely to experience a severe disease course. Treatment with antioxidants has been tested as a potential approach to reduce the effects of this disorder. Here, we present a protocol to assess the impact of treatment with a mixture of curcuminoids on physiological and molecular biomarkers, focusing on determining total antioxidant capacity. We used a cohort of diabetes patients with an imbalance in redox mechanisms as such patients are more likely to become severely ill from COVID-19 than healthy persons.
CITATION STYLE
Guest, P. C., Abbasifard, M., Jamialahmadi, T., Majeed, M., Kesharwani, P., & Sahebkar, A. (2022). Multiplex Testing of Oxidative-Reductive Pathway in Patients with COVID-19. In Methods in Molecular Biology (Vol. 2511, pp. 333–344). Humana Press Inc. https://doi.org/10.1007/978-1-0716-2395-4_25
Mendeley helps you to discover research relevant for your work.